ReadyGo (Diagnostic Equipment) key facts
as of Oct 2026- Developer of a healthcare diagnostics platform intended for the detection of different diseases.
- ReadyGo (Diagnostic Equipment) is valued at approximately $31.6M as of Oct 2026 (last reported valuation).
- It has raised $5.5M; the latest was Later Stage VC ($2.5M) in Mar 2025.
- Notable investors include Maven Capital Partners UK, Midlands Engine Investment Fund, Foresight Group.
- Status: Privately Held (backing).
ReadyGo (Diagnostic Equipment)'s last reported valuation, Mar 2025. Nothing priced has surfaced since.
- ·Watch ReadyGo (Diagnostic Equipment): the Monday email on marks, rounds and moves
ReadyGo (Diagnostic Equipment) funding rounds
No funding rounds for ReadyGo (Diagnostic Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs ReadyGo (Diagnostic Equipment)
3ReadyGo (Diagnostic Equipment) valuation
ReadyGo (Diagnostic Equipment)'s last reported valuation was $31.6 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.
ReadyGo (Diagnostic Equipment) investors
3 investors are on record for ReadyGo (Diagnostic Equipment), including Maven Capital Partners UK, Midlands Engine Investment Fund and Foresight Group.
About ReadyGo (Diagnostic Equipment)
Developer of a healthcare diagnostics platform intended for the detection of different diseases. The company's platform has a commercially ready all-in-one sample collection/preparation device designed for isothermal-based testing and detection of multiple infections, including coronavirus and influenza and also for testing for viral conjunctivitis, herpes and dengue fever which can last for up to several different tests simultaneously, enabling users to get detected for all kinds of infections rapidly and accurately.
- Sector
- Healthcare
- HQ
- Bath, United Kingdom
- Founded
- 2016
- Employees
- 10
- Website
- readygotest.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.